Skip to main content

Analyze

DATA

jradams1
Annotation of

Pecan Street Inc. is a local 501(c)(3) that specializes in producing, analyzing, and sharing data on energy and water consumption practices as well as verifying new “smart home” technologies, electricity pricing, electric vehicle infrastructure, solar energy tech, and energy storage tech. On their company website, Pecan Street Inc. brags about having the largest utility consumption data port in the world and claims to “provide access to the world’s best data on consumer energy and water consumption behavior.” Their data source is a group of over 1000 volunteers that live in the Mueller community, a mixed use residential and commercial zone with its own microgrid that has the highest density of solar panels-plus-electric vehicles in the state of Texas. It was for this reason that the Mueller Community was chosen as one of the Austin locations for a federally funded experiment in energy storage. The project, named Austin SHINES, was co-funded by the DOE’s SunShot Initiative (during Obama’s administration) and the Texas Commission for Environmental Quality to test the efficiency of solar-plus-storage systems at different scales (household, residential/commercial, and utility scales). On October 4, 2018, Pecan Street posted a blog announcing that they had finally “crossed into the Big Data realm. With the acquisition of a few new project servers, [they] have surpassed one petabyte of data storage availability at Pecan Street.”

            According to their website, the data produced at Pecan Street is helping develop technology that can actually increase grid stability while also increasing its efficiency and capacity to incorporate distributed renewable energy resources: “Distributed storage, automated demand response, improved lighting ballasts, power supplies and grid control products can all mitigate or eliminate existing electricity challenges if they are developed using data that details the issues correctly.” Critical data scholars, however, have argued that data always require the presence of human experts to animate them (Gliteman 2013). But how, if at all, is this analytic commitment altered by the development of the “internet-of-things,” where humans are able to set parameters on smart-technology and smart-contracts, running on blockchain, so that these devices respond to data by themselves in real time?

pece_annotation_1472844513

tamar.rogoszinski

This study is published in the Japanese Journal of Clinical Oncology. This journal is for clinical oncologists and publishes articles about medical oncology, clinical trials, radiology, surgery, basic research, epidemiology, and palliative care. It was established in 1971 as the first journal from Japan to publish clinical research on cancer in English. It is a sister-journal to the Journal of the National Cancer Institute. It is also linked through the Oxford Journals. 

pece_annotation_1472844848

tamar.rogoszinski

The article is published in the Japanese Journal of Clinical Oncology. It is meant for clinical oncologists and publishes articles on medical oncology, clinical trials, radiology, surgery, basic research, epidemiology, and palliative care. It was established in 1971 and is the first journal from Japan to publish clinical research on cancer in English. Since 1977, JJCO is a sister-journal to the Journal of the National Cancer Institute and is linked through Oxford Journals. 

pece_annotation_1473005511

Sara_Nesheiwat

This study was written by Kota Katanoda et al and recently published in 2016. The article is published by JJCO (Japanese journal of Clinical Oncology.) This journal publishes many works involving cancer studies and epidemiological studies analyzing the distribution of cancers. This journal focuses on oncology and the medical aspects of causes and effects based off radiation exposure, surgeries mainly focused on effects seen on Asian countries and citizens. The journal focuses on all types of cancers and publishes meta-analyses, as well as systematic reviews of risks that patients face post or pre surgery in terms of cancer, as well as possible reactions to disasters or radiation exposure. This journal has numerous publications as well as has ties to the Oxford Journals, it is regarded as a dependable and noteworthy journal for clinical oncology by peers. It is edited by Tadao Kakizoe and was established in 1971.

pece_annotation_1473112508

jaostrander

This study was puplished in the Japanese Journal of Clinical Oncology. This journal typically puplishes a variety of articles relating to medical oncology, clinical trials, radiology, surgeries, and basic research.The japanese Journal of Clinical Oncology is known for publishing high quality medical articles that relate to the Asian region.

pece_annotation_1473113728

jaostrander

This study was puplished in the Japanese Journal of Clinical Oncology. This journal typically puplishes a variety of articles relating to medical oncology, clinical trials, radiology, surgeries, and basic research.The japanese Journal of Clinical Oncology is known for publishing high quality medical articles that relate to the Asian region.

pece_annotation_1473536575

Alexi Martin

The study is published under emerging infectious diseases from the CDC. The CDC publishes important information about the possibility of widespread infection (such as Zika) and offers ways to avoid outbreak and prevent further infection. The publication is very credible necause the CDC is cited by the government and on various news sources as a way of staying 'safe' from diasese.

pece_annotation_1473536945

Alexi Martin

This study has travelled worldwide. It has been cited in other government websites, in other epilogical studies to support  why diease spreads after flooding. It is used to support preparation for natural disasters. It has been cited by worldwide health officials in their health journals.

pece_annotation_1473604750

Andreas_Rebmann

This study was published in PLOS Medicine, and publishes studies across the spectrum of medical science. It is peer-reviews, and authors pay a publishing fee. It goes against the “cycle of dependency that has formed between the journals and the pharmaceutical industry.” In 2014, PLOS Medicine was given an impact factor (which measures how often studies published in the journal are cited in other studies) of 14.429, ranking 7th out of 153.